Morgan Stanley’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,295,665
| Closed | -$5.97M | – | 8208 |
|
|
2024
Q3 | $5.97M | Buy |
10,295,665
+5,841,638
| +131% | +$3.27M | ﹤0.01% | 3832 |
|
|
2024
Q2 | $2.75M | Sell |
4,454,027
-2,287,863
| -34% | -$1.93M | ﹤0.01% | 4345 |
|
|
2024
Q1 | $17.3M | Sell |
6,741,890
-4,299,016
| -39% | -$10.5M | ﹤0.01% | 2858 |
|
|
2023
Q4 | $22.5M | Buy |
11,040,906
+9,278,665
| +527% | +$16.9M | ﹤0.01% | 3227 |
|
|
2023
Q3 | $3.03M | Sell |
1,762,241
-15,185
| -0.9% | -$27K | ﹤0.01% | 4089 |
|
|
2023
Q2 | $3.47M | Sell |
1,777,426
-55,199
| -3% | -$129K | ﹤0.01% | 4037 |
|
|
2023
Q1 | $5.09M | Sell |
1,832,625
-159,854
| -8% | -$457K | ﹤0.01% | 3778 |
|
|
2022
Q4 | $6.87M | Sell |
1,992,479
-63,828
| -3% | -$182K | ﹤0.01% | 3456 |
|
|
2022
Q3 | $5.29M | Buy |
2,056,307
+768,500
| +60% | +$2.45M | ﹤0.01% | 3642 |
|
|
2022
Q2 | $3.12M | Buy |
1,287,807
+1,093,446
| +563% | +$2.87M | ﹤0.01% | 4171 |
|
|
2022
Q1 | $801K | Buy |
194,361
+160,309
| +471% | +$849K | ﹤0.01% | 5126 |
|
|
2021
Q4 | $437K | Sell |
34,052
-7,789
| -19% | -$86.3K | ﹤0.01% | 5623 |
|
|
2021
Q3 | $451K | Sell |
41,841
-19,084
| -31% | -$174K | ﹤0.01% | 5561 |
|
|
2021
Q2 | $556K | Sell |
60,925
-1,338,583
| -96% | -$12.4M | ﹤0.01% | 5463 |
|
|
2021
Q1 | $13.2M | Buy |
1,399,508
+1,090,080
| +352% | +$15M | ﹤0.01% | 2364 |
|
|
2020
Q4 | $1.22M | Buy |
309,428
+306,707
| +11,272% | +$928K | ﹤0.01% | 4542 |
|
|
2020
Q3 | $7K | Sell |
2,721
-137,976
| -98% | -$512K | ﹤0.01% | 6379 |
|
|
2020
Q2 | $935K | Buy |
140,697
+137,769
| +4,705% | +$928K | ﹤0.01% | 4233 |
|
|
2020
Q1 | $17K | Sell |
2,928
-30,530
| -91% | -$256K | ﹤0.01% | 5871 |
|
|
2019
Q4 | $300K | Buy |
33,458
+26,669
| +393% | +$222K | ﹤0.01% | 5217 |
|
|
2019
Q3 | $59K | Buy |
6,789
+6,136
| +940% | +$62K | ﹤0.01% | 5650 |
|
|
2019
Q2 | $7K | Sell |
653
-658
| -50% | -$7.53K | ﹤0.01% | 6241 |
|
|
2019
Q1 | $17K | Sell |
1,311
-9,293
| -88% | -$124K | ﹤0.01% | 6060 |
|
|
2018
Q4 | $164K | Buy |
+10,604
| New | +$202K | ﹤0.01% | 5362 |
|
Other funds holding GRTS
Morgan Stanley's GRTS Position: Q4 2024 in Review
Morgan Stanley sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 10,295,665 shares — an estimated $5.97M sold.
Morgan Stanley first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $22.5M in Q4 2023. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Morgan Stanley reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Morgan Stanley sold 10,295,665 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $5.97M.
- Morgan Stanley first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
- Morgan Stanley's Gritstone bio, Inc. Common Stock position peaked at $22.5M in Q4 2023.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.